The structure of myostatin: follistatin 288: insights into receptor utilization and heparin binding

被引:139
作者
Cash, Jennifer N. [1 ]
Rejon, Carlis A. [2 ]
McPherron, Alexandra C. [3 ]
Bernard, Daniel J. [2 ]
Thompson, Thomas B. [1 ]
机构
[1] Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA
[2] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada
[3] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD USA
基金
加拿大健康研究院;
关键词
Alk5; follistatin; heparin; myostatin; TGF-beta; GROWTH-FACTOR-BETA; BONE-MORPHOGENETIC PROTEIN; SKELETAL-MUSCLE MASS; TGF-BETA; I RECEPTOR; CRYSTAL-STRUCTURE; ACTIVIN-BINDING; DIFFERENTIATION FACTOR-11; MOLECULAR RECOGNITION; HETEROMERIC COMPLEX;
D O I
10.1038/emboj.2009.205
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Myostatin is a member of the transforming growth factor-beta (TGF-beta) family and a strong negative regulator of muscle growth. Here, we present the crystal structure of myostatin in complex with the antagonist follistatin 288 (Fst288). We find that the prehelix region of myostatin very closely resembles that of TGF-beta class members and that this region alone can be swapped into activin A to confer signalling through the non-canonical type I receptor Alk5. Furthermore, the N-terminal domain of Fst288 undergoes conformational rearrangements to bind myostatin and likely acts as a site of specificity for the antagonist. In addition, a unique continuous electropositive surface is created when myostatin binds Fst288, which significantly increases the affinity for heparin. This translates into stronger interactions with the cell surface and enhanced myostatin degradation in the presence of either Fst288 or Fst315. Overall, we have identified several characteristics unique to myostatin that will be paramount to the rational design of myostatin inhibitors that could be used in the treatment of muscle-wasting disorders. The EMBO Journal (2009) 28, 2662-2676. doi: 10.1038/emboj.2009.205; Published online 30 July 2009 Subject Categories: signal transduction; structural biology
引用
收藏
页码:2662 / 2676
页数:15
相关论文
共 95 条
[1]
BMP-3 and BMP-6 structures illuminate the nature of binding specificity with receptors [J].
Allendorph, George P. ;
Isaacs, Michael J. ;
Kawakami, Yasuhiko ;
Belmonte, Juan Carlos Izpisua ;
Choe, Senyon .
BIOCHEMISTRY, 2007, 46 (43) :12238-12247
[2]
Structure of the ternary signaling complex of a TGF-β superfamily member [J].
Allendorph, George P. ;
Vale, Wylie W. ;
Choe, Senyon .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (20) :7643-7648
[3]
Follistatin complexes Myostatin and antagonises Myostatin-mediated inhibition of myogenesis [J].
Amthor, H ;
Nicholas, G ;
McKinnell, I ;
Kemp, CF ;
Sharma, M ;
Kambadur, R ;
Patel, K .
DEVELOPMENTAL BIOLOGY, 2004, 270 (01) :19-30
[4]
Growth differentiation factor 11 signals through the transforming growth factor-β receptor ALK5 to regionalize the anterior-posterior axis [J].
Andersson, Olov ;
Reissmann, Eva ;
Ibanez, Carlos F. .
EMBO REPORTS, 2006, 7 (08) :831-837
[5]
IDENTIFICATION OF HUMAN ACTIVIN AND TGF-BETA TYPE-I RECEPTORS THAT FORM HETEROMERIC KINASE COMPLEXES WITH TYPE-II RECEPTORS [J].
ATTISANO, L ;
CARCAMO, J ;
VENTURA, F ;
WEIS, FMB ;
MASSAGUE, J ;
WRANA, JL .
CELL, 1993, 75 (04) :671-680
[6]
Electrostatics of nanosystems: Application to microtubules and the ribosome [J].
Baker, NA ;
Sept, D ;
Joseph, S ;
Holst, MJ ;
McCammon, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (18) :10037-10041
[7]
A TRANSFORMING GROWTH-FACTOR-BETA TYPE-I RECEPTOR THAT SIGNALS TO ACTIVATE GENE-EXPRESSION [J].
BASSING, CH ;
YINGLING, JM ;
HOWE, DJ ;
WANG, TW ;
HE, WW ;
GUSTAFSON, ML ;
SHAH, P ;
DONAHOE, PK ;
WANG, XF .
SCIENCE, 1994, 263 (5143) :87-89
[8]
Myostatin as a therapeutic target for musculoskeletal disease [J].
Bradley, L. ;
Yaworsky, P. J. ;
Walsh, F. S. .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2008, 65 (14) :2119-2124
[9]
TYPE-I RECEPTORS SPECIFY GROWTH-INHIBITORY AND TRANSCRIPTIONAL RESPONSES TO TRANSFORMING GROWTH-FACTOR-BETA AND ACTIVIN [J].
CARCAMO, J ;
WEIS, FMB ;
VENTURA, F ;
WIESER, R ;
WRANA, JL ;
ATTISANO, L ;
MASSAGUE, J .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (06) :3810-3821
[10]
Properties of inhibin binding to betaglycan, InhBP/p120 and the activin type II receptors [J].
Chapman, SC ;
Bernard, DJ ;
Jelen, J ;
Woodruff, TK .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2002, 196 (1-2) :79-93